SampledSphere

Resources

Events

Careers

Contact

  • Enquire
  • Services
    • Our labs are your labs

      Sample storage

      • Biobanking Services
      • ICH Stability Storage
      • Photostability Testing
      • Sample Data Storage
      • SampledSphere™

      Sample Management

      • Sample Lifecycle Management
      • Sample Data Management
      • Program Management

      Multiomics

      • Analytical Sample Processing
        • Extraction
        • Blood Fractionation
        • Normalization
        • Sample Processing Quality Control
        • Aliquoting
      • Sequencing
        • Whole-Genome Sequencing
        • Whole Exome Sequencing
        • Targeted Sequencing
        • Sanger Sequencing
        • RNA Sequencing
        • Methylation Sequencing
        • Protein Biomarker Discovery
      • Microarrays
        • Genotyping Arrays
        • Transcriptome Profiling Arrays
        • Methylation Profiling
      • PCR
        • Droplet Digital PCR
        • qPCR
      • Bioinformatics
        • Bioinformatics Analysis
        • Bioinformatics Custom Reporting

      Cellular Services

      • Cell Sample Processing
        • PBMC Isolation
        • Lymphoblastoid cell lines (LCL) Generation & Expansion
        • Fibroblast Generation and Expansion
      • iPSC Services
        • iPSC Reprogramming
        • iPSC Gene Editing
        • iPSC Expansion
        • Neural Progenitor Cell (NPC) differentiation
        • iPSC Quality Control
      • Histology
      • Cell Line Repositories

      Kitting & Logistics

      • Custom Clinical Kitting
      • Sample Logistics
      • Technical Services
      • Validation Services
  • Technology
    • Partner with Sampled and move forward, faster

      Illumina
      Olink
      whole genome sequencing pacbio

      Learn about Service Provision at Sampled

      Our partnerships enable us to provide our clients with access to technology immediately, without the initial overheads and complexities of setting up their own labs. 

      John DelliSanti

      Chief Executive Officer

  • Applications
    • Supporting a wide range of applications:

      Oncology

      Genetic Disorders

      Neurodegenerative Diseases

      Cardiovascular Diseases

      Infectious Diseases

      Autoimmune Diseases

      Metabolic Disorders

      Inflammation

      Substance Abuse

      Our commitment to supporting a wide range of applications, from oncology to substance abuse, underscores our dedication to advancing healthcare and improving patient outcomes across diverse medical challenges.

      View all application areas

      John DelliSanti

      Chief Executive Officer

  • About
    • Learn more about our mission, approach & standards

      About sampled

      Learn more

      Meet the team

      Learn more

      Join the team

      Learn more

      Our Facilities

      Learn more

      Clients Partners

      Learn more
  • Blog
    • News and insights from Sampled and the wider industry

      How Technology Partners Are Pioneering the Future of Genomic Medicine

      May 13, 2025

      Sampled Obtains Wholesale Distribution Authorisation (WDA) Licensing, Expanding Storage Services to the Pharmaceutical and Medical Device Sectors

      April 30, 2025

      Sampled Partners with EBiSC to Expand Access to Stem Cell Lines in the US

      April 8, 2025

      Join us on our blog where we share our passion for unraveling the science of precision medicine, offering practical knowledge and applications from over 25 years of experience in analytical and biorepository services.

      View all our blog posts here

      Mike Sheldon

      Senior Director Scientific Affairs

Search
START TYPING AND PRESS ENTER TO SEARCH
  • Enquire
  • Services
    • Sample Storage
    • Sample Management
    • Multiomics
    • Cellular Services
    • Kitting & Logistics
  • Technology
  • Applications
  • About
  • Blog
  • Resources
  • Careers
  • Events
  • Contact
Search
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

iPSC Quality Control: 4 Important Reasons for Robust Control

December 12, 2023 admin

iPSC Quality Control The field of regenerative medicine has seen remarkable advancements with the discovery of induced pluripotent stem cells (iPSCs), offering new and unprecedented opportunities for disease modeling, drug discovery, and personalized therapeutic applications. However, generating iPSCs is a complex, time consuming process, that requires stringent quality control measures to ensure the reproducibility and integrity of the cells. In this blog, we delve into the top four reasons why you need robust iPSC quality control measures during iPSC generation and discuss the potential consequences of neglecting these measures.

Table of Contents

  • 1. Genomic Stability
  • 2. Cell Line Purity and Homogeneity
  • 3. Functional Pluripotency
  • 4. Viability and Sterility
  • iPSC Quality Control: Conclusion

1. Genomic Stability

One of the biggest concerns in iPSC generation is the potential accumulation of genetic mutations, including copy number variations and single nucleotide variants (SNVs). Without meticulous quality control, undetected genetic aberrations may  compromise the genomic stability of iPSCs, leading to unpredictable downstream effects such as tumorigenicity and impaired differentiation potential.

G-band karyotyping should also be carried out to ensure that no chromosomal abnormalities are present, such whole chromosome deletions or duplications. An analysis of the chromosome banding patterns in iPSCs should always be carried out and compared against the banding pattern of a normal cell.

2. Cell Line Purity and Homogeneity

Contamination with residual non-pluripotent cells during reprogramming poses a significant risk to the purity and homogeneity of iPSC populations. In the absence of stringent quality control, the presence of non-pluripotent cells can compromise the validity of experimental results and potentially introduce genetically abnormal cells into an otherwise homogenous population which would lead to clinical applications needing to be halted for safety concerns.

Inadequate quality control can also lead to the persistence of residual reprogramming factors or vectors, such as Sendai reprogramming vectors, which may elicit an immune response upon transplantation into a host. This immunogenicity poses a significant safety concern for iPSC-based therapies. Rigorous quality control is essential to eliminate or minimize the presence of potentially harmful components, ensuring the safety and efficacy of iPSC-derived products in clinical settings.

ipsc quality control
Improper quality control measures can lead to poor cell viability, pluripotency and ultimately poor reproducibility in your research

3. Functional Pluripotency

The ultimate utility of iPSCs lies in their ability to accurately recapitulate the characteristics of embryonic stem cells, including robust pluripotency and the capacity for directed differentiation. Insufficient quality control measures may result in the generation of iPSCs with compromised pluripotency, limiting their differentiation potential and rendering them unsuitable for downstream applications in disease modeling and therapeutic interventions.

Many tests now exist to ensure that newly generated iPSC populations are indeed pluripotent such as confirming expression of stemness markers through FACS analysis. Through FACS, the dual expression of Oct4 and Tra-1-60 (key stem markers) can be confirmed within the cells. Additionally, analysis of pluripotency can be carried out by demonstrating that the cells can form embryoid bodies that contain each of the three germ line layers. Finally, through gene expression arrays, key genes known to be markers of pluripotency can be assayed. 

4. Viability and Sterility

If you are able to generate genetically normal, pluripotent iPSCs without any residual non-pluripotent cells or reprogramming factors, another consideration is the cell population’s viability and sterility. It isn’t enough to be able to generate a few thousand viable iPSCs at a time when millions or billions of cells are required for your research. Likewise, if you haven’t tested your cells for the presence of microbial contamination (including mycoplasma), your iPSCs may be contaminated leading to loss in viability, cell function and genetic abnormalities.

Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have strict guidelines regarding the quality and safety of cell-based therapies. The presence of mycoplasma contamination in iPSCs violates these regulatory standards, making the cells unsuitable for use in clinical trials.

iPSC Quality Control: Conclusion

In conclusion, the successful harnessing of iPSCs for biomedical applications hinges on the establishment and adherence to stringent quality control measures throughout the generation process. Failure to implement these measures not only jeopardizes the reliability and reproducibility of experimental results but also poses serious safety concerns for the translational use of iPSCs in regenerative medicine.

Sampled’s experts are highly trained at generating iPSCs and carrying out stringent quality control tests to measure pluripotency of newly generated iPSCs as well as ensure they are viable and pure. We understand that not all labs can afford to carry out the necessary quality control procedures they want to, which is why clients work with us to gain peace of mind and save on capital expenditure. To learn more about our iPSC generation services, contact one of our experts today


Filed Under: Why Outsource? Cellular Services

Footer

Sampled logo

Sampled
30 Knightsbridge Road
Building 3, Piscataway, NJ 08854
U.S.A

Tel:  +1-732-273-0699

Latest news

  • How Technology Partners Are Pioneering the Future of Genomic Medicine May 13, 2025
  • Sampled Obtains Wholesale Distribution Authorisation (WDA) Licensing, Expanding Storage Services to the Pharmaceutical and Medical Device Sectors April 30, 2025
  • Sampled Partners with EBiSC to Expand Access to Stem Cell Lines in the US April 8, 2025

Keep up to date

Connect with us on Linkedin

Sign up for our newsletter

Search site

Copyright © 2025 Sampled.com | Legal | Privacy policy | Cookies | Web build by...

Infinity BiologiX LLC, Roylance Stability Storage Limited and Roylance Scientific Limited are doing business as Sampled.

Speak to an expert

Tell us about your requirements and you will be contacted by our staff for personalized assistance

Speak to an expert

Tell us about your requirements and you will be contacted by our staff for personalized assistance

Sign up for our newsletter

Enquiry form

Search sampled.com

Free sample pack

Fill out the form below to receive a sample kitting pack with packaging examples and more information. 

Learn more about our kitting services